Page results
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
An exhibition of photographs from Photographer in Residence Graeme Weston celebrating UCLH’s diverse workforce. Graeme was commissioned to work in UCLH for a period of 6 months developing…
-
Liz O’Hara was appointed as joint chief people officer across UCLH and Whittington Health in March 2024, having held the role of director of workforce at UCLH since March 2020.
-
Chyrel Brown became a non-executive director at UCLH in May 2022 and was appointed as vice-chair in January 2025.
-
Professor Charles Swanton is one of three innovative cancer investigators to be awarded the prestigious Paul Marks Prize for Cancer Research by the Memorial Sloan Kettering Cancer Center (MSK).
-
A very wide range of patients are seen in the epilepsy and neurology clinics – and advice given to you about how best to prepare for an appointment will vary according to your specific…
-
A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.
-
Patient Art Programme Our Arts & Heritage programme for patients spans art, music, and dance - from art workshops on hospital wards delivered by our resident artists to music in our atriums.
File results
-
FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors